Results 91 to 100 of about 1,908,615 (320)

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

open access: yesMolecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed   +10 more
wiley   +1 more source

The Refined Application and Evolution of Nanotechnology in Enhancing Radiosensitivity During Radiotherapy: Transitioning from Gold Nanoparticles to Multifunctional Nanomaterials

open access: yesInternational Journal of Nanomedicine, 2023
Anqi Zhang,1 Lei Gao2 1Oncology Department, Huabei Petroleum Administration Bureau General Hospital, Renqiu, Hebei, People’s Republic of China; 2Medical Imaging Department, Huabei Petroleum Administration Bureau General Hospital, Renqiu, Hebei, People’s ...
Zhang A, Gao L
doaj  

The Measurement of Neutron Contamination in High Energy X-Ray Radiotherapy Using a He-3 Gas Dosimeter [PDF]

open access: yesIranian Journal of Medical Physics
Introduction: Neutron contamination is likely caused by the collision of high-energy photon interactions (γ, ṉ) with heavy metals used in the construction of the accelerator.
Alireza Vejdani   +4 more
doaj   +1 more source

Radiation damage effects on detectors and eletronic devices in harsh radiation environment [PDF]

open access: yes, 2015
Radiation damage effects represent one of the limits for technologies to be used in harsh radiation environments as space, radiotherapy treatment, high-energy phisics colliders.
Fiore, S.
core   +2 more sources

Strength through diversity: how cancers thrive when clones cooperate

open access: yesMolecular Oncology, EarlyView.
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken   +3 more
wiley   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

Intranasal melanoma treated with radiation therapy in three dogs [PDF]

open access: yes, 2017
Three dogs were investigated for chronic unilateral nasal discharge. In all cases CT imaging showed an intranasal mass causing turbinate lysis and no evidence of metastasis.
Blackwood, L   +6 more
core   +4 more sources

Comparison of the Radiation Dose Absorbed to the Testes of Men Undergoing Pelvis Radiotherapy for Cancer

open access: yesمجله دانشکده پزشکی اصفهان, 2007
BACKGROUND: The objective of this study was to measure the radiation dose absorbed by testes in those men receiving pelvic radiotherapy in order to provide appropriate shielding.
Abbas Gookizadeh, Ahmad Shanei
doaj  

MRI-Guided Radiotherapy for Prostate Cancer: a New Paradigm

open access: yesActa Clinica Croatica, 2022
Radiotherapy is one of the key treatment modalities for primary prostate cancer. During the last decade, significant advances were made in radiotherapy technology leading to increasing both physical and biological precision.
Jure Murgić   +6 more
doaj  

Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer [PDF]

open access: yes, 2013
Background: Preoperative radiochemotherapy (RCT) with 5-FU or capecitabine is the standard of care for patients with locally advanced rectal cancer (LARC). Preoperative RCT achieves pathological complete response rates (pCR) of 10-15%.
Arnold, Dirk   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy